Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?
Susanne Walitza1, Birgit Werner, Marcel Romanos
1Department of Child and Adolescent Psychiatry and Psychotherapy, University of Würzburg, Würzburg, Germany.
Environmental Health Perspectives
|June 26, 2007
Summary
Methylphenidate (MPH) treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children did not increase genomic damage. This study found no significant changes in micronuclei frequency, refuting earlier concerns about MPH
Area of Science:
- Pediatric Psychiatry
- Genetics
- Pharmacology
Background:
- Attention Deficit Hyperactivity Disorder (ADHD) affects 6-12% of children and adolescents.
- Methylphenidate (MPH) is a common ADHD treatment, with over 5 million prescriptions annually in the US.
- Previous research suggested MPH may increase genomic damage, raising cancer concerns.
Purpose of the Study:
- To investigate the cytogenetic effects of MPH in children with ADHD.
- To assess potential genomic damage associated with MPH therapy.
- To address concerns regarding the long-term carcinogenic effects of MPH.
Main Methods:
- Prospective study analyzing genomic damage (micronucleus frequency) in lymphocytes of children with ADHD.
- Measurements taken before and at 1, 3, and 6 months after initiating MPH therapy.
- Included a group of children receiving chronic MPH therapy.
Main Results:
- Methylphenidate (MPH) treatment showed no significant alteration in micronucleus frequency.
- The study did not replicate findings of increased genomic damage associated with MPH.
Conclusions:
- Concerns about increased cancer risk from long-term MPH treatment are not supported by this study.
- The cytogenetic effects of MPH in children with ADHD were found to be non-significant.
- This research provides evidence against the carcinogenic potential suggested by earlier studies.
More Related Videos
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...